U. S. Premium Beef, LLC

$ Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000168316824005402 Filed on August 09, 2024

Income Statement

Concept	2024 Q2

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$28.38M
Short-Term Investments
Other Short-Term Assets	$1.104M
YoY Change	4700.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$69.95M
YoY Change	24.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.00K
YoY Change	-15.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.000K
YoY Change	0.0%
Total Long-Term Assets	$167.0M
YoY Change	-12.89%
TOTAL ASSETS
Total Short-Term Assets	$69.95M
Total Long-Term Assets	$167.0M
Total Assets	$236.9M
YoY Change	-4.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.703M
YoY Change	139.42%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$7.524M
YoY Change	-23.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.703M
Total Long-Term Liabilities	$7.524M
Total Liabilities	$10.23M
YoY Change	-6.65%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity	$236.9M
YoY Change	-4.49%

Cashflow Statement

Concept	2024 Q2

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28378000	usd
CY2024Q2	uspb	Certificate Of Deposit CertificateOfDeposit	40000000	usd
CY2024Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	246000	usd
CY2024Q2	uspb	Due From Affiliates Current DueFromAffiliatesCurrent	226000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1104000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	69954000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	275000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	238000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	256000	usd
CY2024Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	166696000	usd
CY2024Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	21000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2083000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	58000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	368000	usd
CY2024Q2	uspb	Distributions Payable DistributionsPayable	152000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2703000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	198000	usd
CY2024Q2	uspb	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	7326000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7524000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	10227000	usd
CY2024Q2	us-gaap	Members Capital MembersCapital	226717000	usd
CY2024Q2	us-gaap	Members Equity MembersEquity	226717000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	236944000	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-28
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58481000	usd
CY2023Q4	uspb	Certificate Of Deposit CertificateOfDeposit	20000000	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	37000	usd
CY2023Q4	uspb	Due From Affiliates Current DueFromAffiliatesCurrent	283000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1675000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	80476000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	274000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	231000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	283000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	162597000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2000	usd
CY2024Q2	us-gaap	Assets Assets	236944000	usd
CY2023Q4	us-gaap	Assets Assets	243401000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	28000	usd
CY2024Q2	uspb	Due To Affiliates Current DueToAffiliatesCurrent	21000	usd
CY2023Q4	uspb	Due To Affiliates Current DueToAffiliatesCurrent	48000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3225000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	56000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	390000	usd
CY2023Q4	uspb	Distributions Payable DistributionsPayable	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3747000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	228000	usd
CY2023Q4	uspb	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	7293000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7521000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11268000	usd
CY2023Q4	us-gaap	Members Capital MembersCapital	232133000	usd
CY2023Q4	us-gaap	Members Equity MembersEquity	232133000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	243401000	usd
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1790000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2298000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1797000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	2308000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1797000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2308000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1639000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1639000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4099000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	22305000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	646000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	315000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6384000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	24259000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4587000	usd
	us-gaap	Net Income Loss NetIncomeLoss	21951000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4587000	usd
	us-gaap	Net Income Loss NetIncomeLoss	21951000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4099000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	22305000	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	10464000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	209000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	201000	usd
	us-gaap	Increase Decrease In Due From Affiliates Current IncreaseDecreaseInDueFromAffiliatesCurrent	-57000	usd
	us-gaap	Increase Decrease In Due From Affiliates Current IncreaseDecreaseInDueFromAffiliatesCurrent	1488000	usd
	uspb	Due From Cobank DueFromCobank	-0	usd
	uspb	Due From Cobank DueFromCobank	212000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-570000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	19000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-7000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	40000	usd
	us-gaap	Increase Decrease In Due To Affiliates Current IncreaseDecreaseInDueToAffiliatesCurrent	-27000	usd
	us-gaap	Increase Decrease In Due To Affiliates Current IncreaseDecreaseInDueToAffiliatesCurrent	-1127000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1109000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1815000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-22000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-755000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-252000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4543000	usd
	uspb	Investment In Certificate Of Deposit InvestmentInCertificateOfDeposit	40000000	usd
	uspb	Investment In Certificate Of Deposit InvestmentInCertificateOfDeposit	20000000	usd
	uspb	Redemption Of Certificates Of Deposit RedemptionOfCertificatesOfDeposit	20000000	usd
	uspb	Redemption Of Certificates Of Deposit RedemptionOfCertificatesOfDeposit	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20000000	usd
	uspb	Member Distributions MemberDistributions	9851000	usd
	uspb	Member Distributions MemberDistributions	48752000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9851000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-48752000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-30103000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-64209000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58481000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97732000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28378000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33523000	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	28400000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	58500000	usd
CY2024Q2	uspb	Tax And Audit Related Expenses TaxAndAuditRelatedExpenses	200000	usd
CY2024Q2	us-gaap	Contractual Obligation ContractualObligation	300000	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	300000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1730000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2075000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	6922000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	6972000	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	8652000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	9047000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	162597000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-682000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	-0	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	161915000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4781000	usd
CY2024Q2	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	-0	usd
CY2024Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	166696000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	179556000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7600000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	-0	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	187156000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	14705000	usd
CY2023Q2	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	10464000	usd
CY2023Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	191397000	usd
	uspb	Equity Method Investments Net Sales EquityMethodInvestmentsNetSales	5522101000	usd
	uspb	Equity Method Investments Costs Of Revenue EquityMethodInvestmentsCostsOfRevenue	5244363000	usd
	uspb	Equity Method Investments Selling General And Administrative Expenses EquityMethodInvestmentsSellingGeneralAndAdministrativeExpenses	52089000	usd
	uspb	Equity Method Investments Depreciation And Amortization EquityMethodInvestmentsDepreciationAndAmortization	62557000	usd
	uspb	Equity Method Investments Total Costs And Expenses EquityMethodInvestmentsTotalCostsAndExpenses	5359009000	usd
	uspb	Equity Method Investments Operating Income Expense EquityMethodInvestmentsOperatingIncomeExpense	163092000	usd
	uspb	Equity Method Investment Income Interest EquityMethodInvestmentIncomeInterest	42000	usd
	uspb	Equity Method Investment Interest Expense EquityMethodInvestmentInterestExpense	11160000	usd
	uspb	Equity Method Investment Summarized Financial Information Net Income Loss Before Taxes EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLossBeforeTaxes	151974000	usd
	uspb	Equity Method Investment Summarized Financial Information Income Tax Expense EquityMethodInvestmentSummarizedFinancialInformationIncomeTaxExpense	1996000	usd
	uspb	Equity Method Investment Profit Loss EquityMethodInvestmentProfitLoss	149978000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	300000	usd
CY2023Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0000	pure
CY2023Q4	us-gaap	Members Capital MembersCapital	232133000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-691000	usd
CY2024Q1	us-gaap	Members Capital MembersCapital	228143000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5278000	usd
CY2024Q2	us-gaap	Members Capital MembersCapital	226717000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7381000	usd
CY2023Q1	us-gaap	Members Capital MembersCapital	271322000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14570000	usd
CY2023Q2	us-gaap	Members Capital MembersCapital	237120000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-005402-index-headers.html	Edgar Link	pending
0001683168-24-005402-index.html	Edgar Link	pending
0001683168-24-005402.txt	Edgar Link	pending
0001683168-24-005402-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uspb-20240629.xsd	Edgar Link	pending
uspb_ex3101.htm	Edgar Link	pending
uspb_ex3102.htm	Edgar Link	pending
uspb_ex3201.htm	Edgar Link	pending
uspb_ex3202.htm	Edgar Link	pending
uspb_i10q-062924.htm	Edgar Link	pending
uspb-20240629_lab.xml	Edgar Link	unprocessable
uspb-20240629_pre.xml	Edgar Link	unprocessable
uspb_i10q-062924_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
uspb-20240629_cal.xml	Edgar Link	unprocessable
uspb-20240629_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

U. S. Premium Beef, LLC

2024 Q2 Form 10-Q Financial Statement

#000168316824005402 Filed on August 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission